JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharma, R. M.
Right arrow Articles by Setlur, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, R. M.
Right arrow Articles by Setlur, R.
Related Collections
Right arrow Critical Care
Right arrow Blood
Right arrow Resuscitation

Anesth Analg 2005;101:833-834
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000175209.61051.7F


CRITICAL CARE AND TRAUMA

Vasopressin in Hemorrhagic Shock

Ram M. Sharma, MD, and Rangraj Setlur, MD

Department of Anaesthesiology & Critical Care, Armed Forces Medical College, Pune, India

Address correspondence to Rangraj Setlur, MD, Armed Forces Medical College, Pune-411040, India. Address electronic mail to rangrajsetlur{at}hotmail.com.


    Abstract
 Top
 Abstract
 Introduction
 Case Reports
 Discussion
 References
 
We describe the treatment of two patients with hemorrhagic shock unresponsive to volume replacement and catecholamines. Both patients responded to a small-dose infusion of vasopressin, which allowed tapering off of the catecholamines. The possible role of small-dose infusions of vasopressin in fluid- and catecholamine-resistant hemorrhagic shock is discussed.


    Introduction
 Top
 Abstract
 Introduction
 Case Reports
 Discussion
 References
 
Fluid resuscitation is the standard of care for hemorrhagic shock. However, a state of resistant hypotension that is not responsive to fluid resuscitation occasionally develops in patients who have prolonged hypotension resulting from massive blood loss. This is presumably caused by accumulation of vasodilatory metabolites as the result of ischemia-reperfusion injury. This hypotension is also not responsive to catecholamines because of coexisting severe acidosis, which inactivates catecholamine receptors. As this situation is analogous to the hypotension seen in septic shock, where vasopressin has been used advantageously, it was presumed that a vasopressin infusion would be beneficial in patients with fluid-resistant hypotension after prolonged hemorrhagic shock. Two cases managed with this approach are described.


    Case Reports
 Top
 Abstract
 Introduction
 Case Reports
 Discussion
 References
 
Case 1
A 61-yr-old male patient presented with periampullary carcinoma and was scheduled for a Whipple procedure. He was hypertensive on amlodipine 5 mg daily, with a preoperative arterial blood pressure of 130/90. His preoperative hemoglobin (Hb) was 8.6 g%.

Induction and maintenance of anesthesia were uneventful. After 2 h of surgery, there was an accidental laceration of the portal vein, leading to profuse bleeding. The patient's arterial blood pressure decreased to 80/40 mm Hg. Ringer's lactate solution, gelfusine, packed red blood cells and fresh-frozen plasma were transfused, and more blood was ordered. His arterial blood pressure decreased to 50/30 mm Hg and his end-tidal CO2 (ETco2) decreased to 15 mm Hg. The patient developed severe bradycardia. Epinephrine 1 mg in 10 mL of saline was administered. A norepinephrine infusion at 0.2 µg · kg–1 · min–1 was started, while fluid replacement was continued with whole blood. His arterial blood pressure remained around 50/30 mm Hg. An arterial blood gas (ABG) at this point showed a pH of 6.9, Pco2 of 44, Pao2 of 185.7, bicarbonate 10.7, and a base deficit of –21. Ninety mEq of sodium bicarbonate was administered and fluid resuscitation was continued for a cumulative total of 11 L of crystalloids, 3 L of colloids, and 3.5 L of blood.

Three hours after the laceration took place the surgeons were able to repair the portal vein and control the hemorrhage. The surgery proceeded. Five hours after laceration of the portal vein his central venous pressure (CVP) was 14 cm H2O. However, his arterial blood pressure remained at approximately 70/40 mm Hg. At this point it was judged that adequate fluid resuscitation had taken place and that there was no response to fluid resuscitation and norepinephrine infusion, indicating resistant vasodilation secondary to prolonged hypovolemic shock.

Vasopressin 0.04 U/min along with dobutamine 5 µg · kg–1 · min–1 was started, and the norepinephrine was gradually discontinued. His arterial blood pressure started increasing after 6 h of intraoperative resuscitation and 1 h of vasopressin. The patient was moved to the intensive care unit (ICU) with an arterial blood pressure of 90/60 mm Hg and a heart rate of 130/min. An ABG at this time showed a pH of 7.27, Pco2 of 20 mm Hg, Po2 of 70.6 mm Hg, Hb of 12.6, and a base deficit of –17.6. Postoperatively, 1.4 L of packed red blood cells and 2 U of platelets were transfused for continuing ooze from the abdominal drains.

After 6 h in the ICU the patient was awake and obeying commands. He had an arterial blood pressure of 104/61, an ABG pH of 7.4, a base deficit of –4, Pco2 of 35, Po2 of 160, Hb 12.0. The vasopressin and dobutamine infusions were tapered off over 8 h and the patient maintained a normal arterial blood pressure. The patient was tracheally extubated the next morning and had an uneventful recovery with no postoperative neurological sequelae.

Case 2
A 53-yr-old patient with stomach carcinoma underwent a distal gastrectomy, gastrojejunostomy, pancreatojejunostomy, and sleeve resection of the neck of the pancreas. His immediate postoperative period was uneventful. On the seventh postoperative day he developed secondary hemorrhage and had 2 L of hematemesis. He had a cardiac arrest while being endotracheally intubated. He was defibrillated, resuscitated with IV colloids, and rushed to the operating room within 30 min. There, a distal pancreaticosplenectomy to control multiple bleeding vessels was performed and a feeding jejunostomy was inserted. Intraoperatively the patient had severe hypotension and asystolic cardiac arrest after 15 min of laparotomy. He was resuscitated with internal cardiac massage and crystalloid, blood and fresh-frozen plasma transfusions and epinephrine boluses. Bleeding was controlled 2 h after surgery started.

The patient's total blood loss was estimated to be approximately 6 L. His CVP was 10 cm after cumulative transfusion of 13 L of crystalloids and 11 L colloids, including 5 L of blood and 1 L of fresh-frozen plasma. He continued to be severely hypotensive, and dobutamine at 10 µg · kg–1 · min–1 and norepinephrine at 0.5 µg · kg–1 · min–1 were added. He remained hypotensive at an arterial blood pressure of 80/50 mm Hg despite these measures.

Five hours after surgery started, vasopressin was started at a dose of 0.04 U/min. Within half an hour the patient's arterial blood pressure increased to 110/70 mm Hg. A blood gas analysis performed at this time revealed severe metabolic acidosis (pH, 7.1; base deficit, –11.4). Ventilation was continued and sodium bicarbonate was administered to correct the base deficit.

The patient was moved to the ICU. His mean arterial blood pressure remained more than 65 mm Hg. His base deficit was corrected over the next 24 h. Vasopressin was tapered off over 24 h and norepinephrine over 48 h. The patient remained hemodynamically stable and was tracheally extubated on the third day. After this, however, he developed an anastomotic leak and intraabdominal sepsis and died of multiorgan failure on postoperative day 15.


    Discussion
 Top
 Abstract
 Introduction
 Case Reports
 Discussion
 References
 
Hypovolemic shock of marked severity and duration may progress to cardiovascular collapse that is unresponsive to volume replacement and catecholamine infusion (1). Vasopressin deficiency may contribute to the pathogenesis of irreversible shock (2). The two patients described had severe bleeding with prolonged and severe hypotension that could not be reversed despite volume replacement and catecholamine pressors.

Vasopressin has been found to be of use in the irreversible phase of hemorrhagic shock in animal studies (3,4) and in isolated case reports (5). Under normal conditions, the doses of vasopressin used have little or no pressor action (3,6), and significant increase of plasma vasopressin as a result of unregulated release of the hormone (i.e., in the syndrome of inappropriate secretion of antidiuretic hormone) does not cause hypertension (4,7). Vasopressin may be effective in resistant hemorrhagic shock resulting from inhibition of KATP channels and inhibition of nitric oxide-induced accumulation of cGMP. Replacement of depleted stores of vasopressin in the neurohypophysis may also contribute to reversal of shock (8).

Fluid-resistant hemorrhagic shock is not common, and adequate volume resuscitation is nearly always effective in resuscitation of hypovolemic patients. However, hemorrhagic shock, when advanced, can become poorly responsive to both volume and catecholamine pressors because of resistant vasodilatation and acidosis. Vasopressin may be a useful adjunct in the treatment of such cases.


    Footnotes
 
Accepted for publication March 14, 2005.


    References
 Top
 Abstract
 Introduction
 Case Reports
 Discussion
 References
 

  1. Walley KR, Wood LDH. Shock. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of critical care. New York: McGraw-Hill, 1998:277–301.
  2. Robin JK, Oliver JA, Landry DW. Vasopressin deficiency in the syndrome of irreversible shock. J Trauma 2003;54(Suppl):S149–54.[Medline]
  3. Raedler C, Voelckel WG, Wenzel V, et al. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin. Anesth Analg 2004;98:1759–61.[Abstract/Free Full Text]
  4. Voelckel WG, Raedler C, Wenzel V, et al. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med 2003;31:1160–5.[Web of Science][Medline]
  5. Morales D, Madigan J, Cullinane S, et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999;20:100:226–9.
  6. Tsai Y-T, Lee F-Y, Linc H-C, et al. Hyposensitivity to vasopressin in patients with hepatitis B-related cirrhosis during acute variceal hemorrhage. Hepatology 1991;13:407–12.[Web of Science][Medline]
  7. Padfield PL, Brown JJ, Lever AF, et al. Blood pressure in acute and chronic vasopressin excess. N Engl J Med 1981;304:1067–70.[Abstract]
  8. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system, Part 2 - clinical physiology. Crit Care 2004;8:15–23.[Web of Science][Medline]



This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
B. A Doepker, M. R Lucarelli, A. Lehman, and M. B. Shirk
Thromboembolic Events During Continuous Vasopressin Infusions: A Retrospective Evaluation
Ann. Pharmacother., September 1, 2007; 41(9): 1383 - 1389.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. V. Roth
The use of vasopressin bolus to treat refractory hypotension secondary to reperfusion during orthotopic liver transplantation.
Anesth. Analg., July 1, 2006; 103(1): 261 - 261.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. V. Roth
Bolus vasopressin during hemorrhagic shock?
Anesth. Analg., June 1, 2006; 102(6): 1908 - 1908.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. H. Stadlbauer, V. Wenzel, A. C. Krismer, W. G. Voelckel, and K. H. Lindner
Vasopressin During Uncontrolled Hemorrhagic Shock: Less Bleeding Below the Diaphragm, More Perfusion Above
Anesth. Analg., September 1, 2005; 101(3): 830 - 832.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharma, R. M.
Right arrow Articles by Setlur, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, R. M.
Right arrow Articles by Setlur, R.
Related Collections
Right arrow Critical Care
Right arrow Blood
Right arrow Resuscitation


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press